Ultraviolet and Light Amplification by Stimulated Emission of Radiation (LASER) in vitiligo

A randomised controlled trial of Light Amplification by Stimulated Emission of Radiation (LASER) application and ultraviolet application on decreasing the area affected by vitiligo.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12610000581066

Enrollment

Registered

2010-07-20

Start date

2010-06-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The purpose of the study was evaluated the application of ultraviolet and LASER in patients with vitiligo. It was selected 22 subjects with vitiligo. Both are interventions groups. They were divided in 2 groups: A and B. the group A (n=11) was submitted by LASER applications and the group B by ultraviolet. the LASER was Heluim Neon (HeNE), density 6j/cm2, pontual tecnique 1minutes and 15 s per point. The total points and session is area dependent. It was about 15 minutes. The LASER was applied transcutaneously and realized 2 sessions per week, totalizing 10 sessions. The patients were reevaluated after 10 sessions. The ultraviolet was narrow band B therapy. It was applied twice a week, during 5 week, totalizing 10 sessions. The dose of ultraviolet was determined by Saidman test. The duration of session was about 5 minutes. The area of despigmentation was measure in the corel drawn computer program.

Interventions

It was selected 22 subjects with vitiligo. Both are interventions groups. They were divided in 2 groups: A and B. the group A (n=11) was submited by LASER applications and the group B by ultraviolet. the LASER was Heluim Neon (HeNE), density 6j/cm2, pontual tecnique 1 minute and 15 s per point. The total points and session is area dependent. It was about 15 minutes. The LASER was applied transcutaneously and realized 2 sessions per week, totalizing 10 sessions. The patients were reevaluated afte

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Healthy volunteers

Inclusion criteria

vitiligo disease

Exclusion criteria

other dermatology diseases exposed by sun frequently under medication

Outcome results